Blackstone (BX) and Carlyle (CG)-backed Medline has postponed its planned initial public offering amid market volatility tied to US President Donald Trump's import tariffs, The Financial Times reported Friday, citing people familiar with the matter.
Medtech company Medline was targeting a valuation close to $50 billion and had planned to file its listing paperwork this week, the FT reported.
Virtual physical therapy provider Hinge Health, which filed its paperwork last month, has also delayed its investor roadshow amid unsettled market conditions, sources reportedly said.
Medline, Hinge Health, Blackstone and Carlyle did not immediately respond to requests for a comment from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。